Literature DB >> 9822058

Platelet-active drugs: the relationships among dose, effectiveness, and side effects.

C Patrono1, B Coller, J E Dalen, V Fuster, M Gent, L A Harker, J Hirsh, G Roth.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9822058     DOI： 10.1378/chest.114.5_supplement.470s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  24 in total

1.  Cardiac Causes of Stroke.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

2.  The application of thromboelastogram in detection of indexes of antiplatelet therapy for coronary heart disease.

Authors:  Shu-Wu Zhao; Yu-Ping Wang; Lin-Dong Xu; Wei Gang
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 3.  Antiplatelet treatment in stable coronary artery disease.

Authors:  Charles J Knight
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

4.  Regeneration of a Pediatric Alveolar Cleft Model Using Three-Dimensionally Printed Bioceramic Scaffolds and Osteogenic Agents: Comparison of Dipyridamole and rhBMP-2.

Authors:  Christopher D Lopez; Paulo G Coelho; Lukasz Witek; Andrea Torroni; Michael I Greenberg; Dean L Cuadrado; Audrey M Guarino; Jonathan M Bekisz; Bruce N Cronstein; Roberto L Flores
Journal:  Plast Reconstr Surg       Date:  2019-08       Impact factor: 4.730

Review 5.  Aspirin resistance, an emerging, often overlooked, factor in the management of patients with coronary artery disease.

Authors:  Amgad N Makaryus
Journal:  Clin Cardiol       Date:  2006-04       Impact factor: 2.882

6.  Dipyridamole enhances osteogenesis of three-dimensionally printed bioactive ceramic scaffolds in calvarial defects.

Authors:  Jonathan M Bekisz; Roberto L Flores; Lukasz Witek; Christopher D Lopez; Christopher M Runyan; Andrea Torroni; Bruce N Cronstein; Paulo G Coelho
Journal:  J Craniomaxillofac Surg       Date:  2017-11-21       Impact factor: 2.078

Review 7.  Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.

Authors:  W S Aronow
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

8.  Oral single high-dose aspirin results in a long-lived inhibition of anodal current-induced vasodilatation.

Authors:  S Durand; B Fromy; A Koïtka; M Tartas; J L Saumet; P Abraham
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

Review 9.  Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events.

Authors:  Joonseok Kim; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

10.  Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.

Authors:  Yanni Chen; Michelle Peate; Rajneesh Kaur; Bettina Meiser; Tim Wong; Judy Kirk; Robyn L Ward; Annabel Goodwin; Finlay Macrae; Janet Hiller; Alison H Trainer; Gillian Mitchell
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.